How do depressed rats respond to psychedelics? New data offer insight into the human experience

Despite tricky regulations, research evaluating the antidepressant potential of psychedelics in humans is mushrooming — and the FDA has already approved a nasal spray concoction of the cat tranquilizer ketamine for patients whose depression persists despite conventional therapy. But scientists still don’t quite fully understand the antidepressant impact of psychedelics on the brain — are … Continue reading How do depressed rats respond to psychedelics? New data offer insight into the human experience